Bullish option flow detected in TG Therapeutics with 8,071 calls trading, 1.4x expected, and implied vol increasing almost 7 points to 112.38%. Feb-23 20 calls and Feb-23 18 calls are the most active options, with total volume in those strikes near 4,100 contracts. The Put/Call Ratio is 0.04. Earnings are expected on February 28th.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TGTX:
- TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab) in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
- TG Therapeutics management to meet virtually with Cantor Fitzgerald
- TG Therapeutics call buyer realizes 91% same-day gains
- TG Therapeutics announces commercial launch of BRIUMVI
- TG Therapeutics Announces Commercial Launch of BRIUMVI™ (ublituximab-xiiy) for the Treatment of Adult Patients with Relapsing Forms of Multiple Sclerosis